AVTR - Avantor Inc.
Close
25.84
0.050 0.193%
Share volume: 3,853,228
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$25.79
0.05
0.19%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-28 | 2023-02-14 | 2023-04-28 | 2023-07-28 | 2023-10-27 | 2024-02-14 | 2024-04-26 | 2024-07-26 | |
| Assets | |||||||||
| Total Assets | 13.113 B | 13.464 B | 13.396 B | 13.063 B | 12.798 B | 12.973 B | 12.763 B | 12.694 B | |
| Current Assets | 2.560 B | 2.658 B | 2.627 B | 2.499 B | 2.385 B | 2.385 B | 2.321 B | 2.329 B | |
| Inventories | 905.000 M | 913.500 M | 904.000 M | 890.400 M | 850.300 M | 828.100 M | 810.600 M | 795.600 M | |
| Other Current Assets | 158.100 M | 153.100 M | 151.500 M | 156.300 M | 147.300 M | 143.700 M | 145.900 M | 132.000 M | |
| Short Term Investments | 158.100 M | 153.100 M | 151.500 M | 156.300 M | 147.300 M | 143.700 M | 145.900 M | 132.000 M | |
| Total Receivables | 1.231 B | 1.218 B | 1.277 B | 1.216 B | 1.150 B | 1.150 B | 1.130 B | 1.129 B | |
| Current Cash | 265.600 M | 372.900 M | 294.600 M | 236.400 M | 236.900 M | 262.900 M | 234.900 M | 272.600 M | |
| Total Non-current Assets | 10.553 B | 10.806 B | 10.769 B | 10.564 B | 10.413 B | 10.588 B | 10.442 B | 10.364 B | |
| Property Plant Equipment | 698.200 M | 727.000 M | 736.500 M | 698.200 M | 698.300 M | 737.500 M | 739.700 M | 753.800 M | |
| Other Assets | 244.600 M | 293.500 M | 272.500 M | 276.700 M | 289.200 M | 358.300 M | 367.700 M | 368.100 M | |
| Intangible Assets | 4.099 B | 4.133 B | 4.077 B | 3.895 B | 3.788 B | 3.775 B | 3.663 B | 3.583 B | |
| Goodwill | 5.511 B | 5.653 B | 5.683 B | 5.694 B | 5.638 B | 5.717 B | 5.672 B | 5.660 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 13.113 B | 13.464 B | 13.396 B | 13.063 B | 12.798 B | 12.973 B | 12.763 B | 12.694 B | |
| Total liabilities | 8.522 B | 8.609 B | 8.401 B | 8.052 B | 7.699 B | 7.720 B | 7.427 B | 7.259 B | |
| Total current liabilities | 1.552 B | 1.659 B | 1.670 B | 1.550 B | 1.488 B | 1.480 B | 1.442 B | 1.465 B | |
| Accounts Payable | 768.900 M | 758.200 M | 765.700 M | 686.600 M | 655.800 M | 625.900 M | 573.400 M | 657.400 M | |
| Other liabilities | 334.100 M | 295.400 M | 300.100 M | 268.800 M | 271.300 M | 350.300 M | 360.700 M | 361.900 M | |
| Current long term debt | 280.600 M | 364.200 M | 325.200 M | 314.000 M | 335.600 M | 259.900 M | 299.100 M | 258.400 M | |
| Long term debt | 5.908 B | 5.923 B | 5.736 B | 5.570 B | 5.291 B | 5.277 B | 5.024 B | 4.857 B | |
| Other liabilities | 334.100 M | 295.400 M | 300.100 M | 268.800 M | 271.300 M | 350.300 M | 360.700 M | 361.900 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.591 B | 4.855 B | 4.995 B | 5.011 B | 5.099 B | 5.253 B | 5.336 B | 5.435 B | |
| Common stock | 674.100 M | 675.200 M | 674.700 M | 675.300 M | 676.000 M | 676.400 M | 678.100 M | 679.400 M | |
| Retained earnings | 1.029 B | 1.170 B | 1.292 B | 1.285 B | 1.393 B | 1.492 B | 1.552 B | 1.645 B |